1 / 6

Ulcerative Colitis Drug Market Size, Industry Analysis, Production Cost, Growth and Forecasts to 2027

Market Size u2013 USD 6.79 Billion in 2018, Market Growth - CAGR of 4.6%, Market Trends u2013 The rising demand for biosimilars

ronnie951
Download Presentation

Ulcerative Colitis Drug Market Size, Industry Analysis, Production Cost, Growth and Forecasts to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ulcerative Colitis Drug Market To Reach USD 10.25 Billion By 2027

  2. Market Summary Market Size – USD 6.79 Billion in 2018, Market Growth - CAGR of 4.6%, Market Trends – The rising demand for biosimilars The global ulcerative colitis drug market is forecast to reach USD 10.25 Billion by 2027, according to a new report by Reports and Data. Ulcerative colitis (UC) can be defined as an inflammatory bowel disease, which is chronic in nature. Some of the mentionable symptoms associated with the condition is inflammation, irritation, and ulcers in the lining of the colon. Further key findings from the report suggest The Ulcerative Colitis Drug market held a market share of USD 6.79 Billion in the year 2018 that is forecasted to grow at a rate of 4.6% during the forecast period. • In context to Drug Type, the Biologics segment generated the highest revenue of USD 2.78 Billion in 2018, with a CAGR of 4.6% during the forecast period. The effectiveness of Biologics in working in a selective manner, rather than affecting the whole body that results in reducing medication-related side effects and elevated preference among care providers and care users contributes to the revenue generated by this segment. • www.reportsanddata.com

  3. Market Summary Key Players: Bausch Health Companies Inc. (Salix Pharmaceutical), AbbVie Inc., Johnson and Johnson, Boehringer Ingelheim GmbH, Novartis AG, Merck & Co., Teva Pharmaceuticals Ltd., Takeda Pharmaceuticals, Shire, Pfizer Inc. Segmentation: Drug Type Outlook (Revenue, USD Billion; 2016-2027) Biologics Corticosteroids Immunomodulators 5-aminosalicylic acid Immunosuppressant Biosimilars Others Route of Administration Outlook (Revenue, USD Billion; 2016-2027) Oral Injectable To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2379 www.reportsanddata.com

  4. Market Summary Application Outlook (Revenue, USD Billion; 2016-2027) Proctosigmoiditis Ulcerative proctitis Pancolitis Left-sided colitis Acute severe ulcerative colitis Regional Outlook for Ulcerative Colitis Drug Market analyses the following geographies: North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Avail this report at Attractive Discount rates! Click here to know more @ https://www.reportsanddata.com/discount-enquiry-form/2379 www.reportsanddata.com

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related